CenterWatch

Clinical Trial Details

NCT ID: NCT01685905
Date Last Changed: September 17, 2012

Overview

Research Study Summary

Patients are needed to participate in a clinical research study for the treatment of Rheumatic Disease, Rheumatoid Arthritis, Ankylosing Spondylitis or Tuberculosis

Research Study Title

Evaluation of the Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Mycobacterium Tuberculosis Infection in Korean Patients With Rheumatic Diseases

Purpose

The purposes of this study

  1. to compare the positivity of tuberculin skin test(TST) and QuantiFERON-TB Gold (QFT-G), and determine the level of agreement between two tests in patients with rheumatic diseases

  2. to evaluate the difference in the occurrence of active TB in patients who receive both QFT-G and TST compared with those who receive only TST for detecting of Latent tuberculosis infection(LTBI) who are candidates of TNF inhibitors.

To Learn more

Recruitment Details

Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Lead Sponsor
Hanyang University
Duration
17 Months
Facility Type
N/A
Compensation

Eligibility

Both Male and Female ages up to N/A

Inclusion Criteria:

  • patients with rheumatic diseases who examined TST or QFT-G in Hanyang university hospital from 2004 to 2010

Exclusion Criteria:

  • N/A

Site Locations (1)

Country State City Zip Facility and Contact
Korea, Republic of Sung-dong Gu Seoul 133-792 Hanyang University Hospital for rheumatic disease
Sang-cheol Bae, MD
82-2-2290-9230
scbae@hanyang.ac.kr

Contact

Sang-cheol Bae, director
82-2-2290-8260
E-mail:

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.